Literature DB >> 19883270

Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose.

Jørgen Valeur1, Mette Helvik Morken, Elisabeth Norin, Tore Midtvedt, Arnold Berstad.   

Abstract

OBJECTIVE: Malabsorption of low-digestible carbohydrates is physiological, but poorly tolerated in some patients. We investigated symptom anticipation and microbial fermentation as possible mechanisms of carbohydrate intolerance in patients with self-reported food hypersensitivity.
MATERIAL AND METHODS: In a randomized, double-blind, cross-over study, 27 consecutive patients with unexplained, self-reported food hypersensitivity were given 10 g lactulose and 10 g glucose (placebo). Symptoms and pulmonary excretion of hydrogen and methane were assessed. Short-chain fatty acids (SCFAs), lactate and prostaglandin E(2) (PGE(2)) were analyzed in rectal dialysis fluid, and compared to dialysates from nine healthy volunteers.
RESULTS: Post-lactulose symptom scores were correlated with habitual symptom scores (r = 0.6, p = 0.001), significantly higher than post-glucose symptom scores (p = 0.01) and significantly higher in patients than controls (p = 0.0007). Levels of SCFAs, lactate and PGE(2) in rectal dialysates were not significantly different after lactulose and glucose, or between patients and controls. Hydrogen excretion was not correlated with symptom scores.
CONCLUSIONS: The findings suggest that self-reported food hypersensitivity is related to microbial fermentation of malabsorbed carbohydrates and not to symptom anticipation solely. Levels of SCFAs, lactate and PGE(2) in rectal dialysates could not explain the fermentation-associated hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883270     DOI: 10.3109/00365520903348684

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  "Gährungsdyspepsie" Revisited.

Authors:  Jørgen Valeur; Ragnhild Undseth; Arnold Berstad
Journal:  Am J Gastroenterol       Date:  2016-01       Impact factor: 10.864

2.  Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad?

Authors:  Arnold Berstad; Ragnhild Undseth; Ragna Lind; Jørgen Valeur
Journal:  Scand J Gastroenterol       Date:  2012-05-18       Impact factor: 2.423

3.  Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot study.

Authors:  Kine Gregersen; Ragna A Lind; Jørgen Valeur; Tormod Bjørkkjær; Arnold Berstad; Gülen Arslan Lied
Journal:  Int J Gen Med       Date:  2010-12-06

4.  Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?

Authors:  Jørgen Valeur; Mette Helvik Morken; Elisabeth Norin; Tore Midtvedt; Arnold Berstad
Journal:  Clin Exp Gastroenterol       Date:  2010-07-07

5.  Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation.

Authors:  Ragnhild Undseth; Arnold Berstad; Jørgen Valeur
Journal:  Mol Med Rep       Date:  2016-10-21       Impact factor: 2.952

6.  Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders.

Authors:  C H Wilder-Smith; A Materna; C Wermelinger; J Schuler
Journal:  Aliment Pharmacol Ther       Date:  2013-04-09       Impact factor: 8.171

7.  Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact Scale.

Authors:  Ragna Lind; Arnold Berstad; Jan Hatlebakk; Jørgen Valeur
Journal:  Clin Exp Gastroenterol       Date:  2013-07-04

8.  Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome.

Authors:  Ragnhild Undseth; Greta Jakobsdottir; Margareta Nyman; Arnold Berstad; Jørgen Valeur
Journal:  Clin Exp Gastroenterol       Date:  2015-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.